Dorman Products - DORM Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dorman Products in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DORM shares.
View DORM analyst ratings or view top-rated stocks.

3 brokers have issued 12 month target prices for Dorman Products' shares. Their DORM share price forecasts range from $101.00 to $130.00. On average, they predict the company's stock price to reach $120.00 in the next year. This suggests a possible upside of 44.8% from the stock's current price.
View analysts price targets for DORM or view top-rated stocks among Wall Street analysts.

Dorman Products' stock was trading at $113.01 at the beginning of 2022. Since then, DORM shares have decreased by 26.7% and is now trading at $82.89.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, October 24th 2022.
View our DORM earnings forecast.

Dorman Products, Inc. (NASDAQ:DORM) announced its earnings results on Monday, July, 25th. The auto parts company reported $1.29 EPS for the quarter, missing the consensus estimate of $1.31 by $0.02. The auto parts company earned $417.40 million during the quarter, compared to analyst estimates of $400.57 million. Dorman Products had a net margin of 8.96% and a trailing twelve-month return on equity of 17.00%. Dorman Products's quarterly revenue was up 34.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.10 EPS.

Dorman Products updated its FY 2022 earnings guidance on Monday, August, 1st. The company provided earnings per share guidance of $5.00-$5.20 for the period, compared to the consensus EPS estimate of $5.53. The company issued revenue guidance of $1.60 billion-$1.64 billion, compared to the consensus revenue estimate of $1.65 billion.

0 employees have rated Dorman Products Chief Executive Officer Kevin M. Olsen on Glassdoor.com. Kevin M. Olsen has an approval rating of 65% among the company's employees. 48.0% of employees surveyed would recommend working at Dorman Products to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dorman Products investors own include AbbVie (ABBV), Intel (INTC), Exxon Mobil (XOM), International Business Machines (IBM), Gilead Sciences (GILD), Wells Fargo & Company (WFC), Abbott Laboratories (ABT), General Motors (GM), JPMorgan Chase & Co. (JPM) and 3M (MMM).

Dorman Products trades on the NASDAQ under the ticker symbol "DORM."

Dorman Products' stock is owned by many different institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (3.50%), State Street Corp (2.98%), Royce & Associates LP (2.08%), abrdn plc (1.80%), Geneva Capital Management LLC (1.58%) and Loomis Sayles & Co. L P (1.55%). Insiders that own company stock include Jeffery Darby and Michael Kealey.
View institutional ownership trends.

Shares of DORM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DORM stock can currently be purchased for approximately $82.89.

Dorman Products (NASDAQ:DORM) has a market capitalization of $2.61 billion and generates $1.35 billion in revenue each year. The auto parts company earns $131.53 million in net income (profit) each year or $4.42 on an earnings per share basis.

The company employs 3,360 workers across the globe.

Dorman Products' mailing address is 3400 East Walnut Street, Colmar PA, 18915. The official website for the company is www.dormanproducts.com. The auto parts company can be reached via phone at (215) 997-1800, via email at investorrelations@dormanproducts.com, or via fax at 215-997-1741.